SII Covishield gets nod for phase 2 and 3 human trials

Pune-based Serum Institute of India (SII) has been given a nod by the Drugs Controller General of India (DCGI) in order to conduct the Phase 2 and 3 human clinical trials of Coronavirus vaccine. The vaccine is known as Covishield. 

This is great news for India as today only a Coronavirus vaccine can help the patients

Take a look